Astellas Pharma Inc (FRA:YPHA)
€ 12.7 +0.50 (+4.1%) Market Cap: 22.75 Bil Enterprise Value: 24.58 Bil PE Ratio: 11.64 PB Ratio: 2.18 GF Score: 75/100

Full Year 2025 Astellas Pharma Inc Earnings Presentation Transcript

Apr 25, 2025 / 08:00AM GMT
Release Date Price: €8.15 (-2.98%)
Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & Investor Relations Officer

Thank you very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot